WaveMan
WaveMan · Company
INFU · Infusystem Holdings, Inc
> Search tickers & screens ⌘K
LIVE
← All companies

INFU InfuSystem (INFU) Insider Trading, Ownership & Congress Trades

Medical Devices · Surgical & medical instruments & apparatus · CIK 0001337013
Quote by TradingView
Cluster · 3 insidersC-suite buying · 2
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
56
13F, latest reported quarter
Conversions, 180 days
8
Codes C/M, not in net · $0 priced

What the filings say about INFU

Insiders, 180 days
+$131.5K net bought
3 buyers

InfuSystem insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, InfuSystem Holdings, Inc insiders bought a net $131.5K of stock across 69 Form 4 purchases and sales, with 3 insiders buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
Lachance Carrie
President and CEO
BUY
2026-05-12 SECtraded 2026-05-11
1,000
$8.5K
+69.8%
Context
  • 4 earlier Form 4 trades (code P or S) here by this insider (4 buys), the last on May 8, 2026.
  • +48.1% median (+46.0% mean) 90-day return after 4 previous buys.
  • The trade is 0.4% of the 238,123 shares held after it.
  • 2 other insiders bought within 30 days.
  • 56 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO Lachance Carrie bought about $8.5K of INFU on May 11, 2026; 2 other insiders bought within 30 days and 56 funds added in the latest 13F quarter.
GENDRON PAUL ANDREW
Director
BUY
2026-05-12 SECtraded 2026-05-08
5,000
$44.4K
+69.8%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on May 20, 2024.
  • -11.9% median (-11.9% mean) 90-day return after 2 previous buys.
  • The trade is 7.1% of the 70,000 shares held after it.
  • 2 other insiders bought within 30 days.
  • 56 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director GENDRON PAUL ANDREW bought about $44.4K of INFU on May 8, 2026, the largest insider purchase at the company since 2022; 2 other insiders bought within 30 days and 56 funds added in the latest 13F quarter.
Lachance Carrie
President and CEO
BUY
2026-05-12 SECtraded 2026-05-08
2,000
$17.7K
+69.8%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on May 16, 2025.
  • +55.0% median (+47.6% mean) 90-day return after 3 previous buys.
  • The trade is 0.8% of the 237,123 shares held after it.
  • 2 other insiders bought within 30 days.
  • 56 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO Lachance Carrie bought about $17.7K of INFU on May 8, 2026; 2 other insiders bought within 30 days and 56 funds added in the latest 13F quarter.
Steele Barry G
Executive VP and CFO
BUY
2026-05-12 SECtraded 2026-05-08
7,000
$61.0K
+69.8%
Context
  • 4 earlier Form 4 trades (code P or S) here by this insider (4 buys), the last on Mar 2, 2026.
  • +15.3% median (+22.9% mean) 90-day return after 4 previous buys.
  • The trade is 7.2% of the 96,590 shares held after it.
  • 2 other insiders bought within 30 days.
  • 56 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive VP and CFO Steele Barry G bought about $61.0K of INFU on May 8, 2026, the largest insider purchase at the company since 2022; 2 other insiders bought within 30 days and 56 funds added in the latest 13F quarter.
Steele Barry G
Executive VP and CFO
BUY
2026-03-02 SEC
2,064
$18.9K
+51.9%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on May 14, 2025.
  • +32.5% median (+31.7% mean) 90-day return after 3 previous buys.
  • The trade is 2.3% of the 88,000 shares held after it.
  • No other insider bought within 30 days.
  • 56 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive VP and CFO Steele Barry G bought about $18.9K of INFU on Mar 2, 2026; 56 funds added in the latest 13F quarter.
69 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 64 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net +$131.5K over 180 days
more than 73% of Medical Devices
Congress
no House purchase disclosed in the last 12 months
Funds
56 funds bought in last quarter
below 54% of Medical Devices
Revenue
+6.4% year over year
below 61% of Medical Devices
Margin
4.6% net margin
more than 73% of Medical Devices
Buybacks
$4.4M repurchased, FY to 2026-06-30
below 75% of Medical Devices
Short interest
4.6% of the float short (float per yahoo 2026-10-26) · 5.2 days to cover · settled 2026-09-30
more than 59% of Medical Devices
What changed in the last 30 days
Oct 27Insider buying stopped: no purchases in 90 days after 4 in the prior 90
Why it matters
The absence is the signal: 4 purchases in one 90-day window and none in the next is a change of behaviour, not a filing.

Watch INFU

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+42.4%12M
-24%-1%+22%+45%2025-102025-122026-022026-042026-062026-082026-10 2026-05-08 · Steele Barry G bought $61.0K2026-05-08 · GENDRON PAUL ANDREW bought $44.4K2026-03-02 · Steele Barry G bought $18.9K2026-05-08 · Lachance Carrie bought $17.7K2026-05-11 · Lachance Carrie bought $8.5K
Insider buy
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns INFU: institutional holders (13F)

13F holdings, latest reported quarter
BlackRock, Inc.
1,585,415 sh
$15.3M
Minerva Advisors LLC
1,348,617 sh
$13.0M
First Eagle Investment Management, LLC
1,240,000 sh
$12.0M
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.
834,750 sh
$8.1M
VANGUARD CAPITAL MANAGEMENT LLC
790,775 sh
$7.6M

Congress trades in INFU

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

INFU planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

INFU mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
North Star Micro Cap Fund
$1.7M position · as of 2026-05-31
0.9%
TETON Westwood Mighty Mites Fund
$1.8M position · as of 2026-06-30
0.8%
ACUITAS US MICROCAP FUND
$919.2K position · as of 2026-06-30
0.8%
DIAMOND HILL SMALL CAP FUND
$2.2M position · as of 2026-06-30
0.7%
Ultra-Small Company Fund
$596.4K position · as of 2026-06-30
0.6%
Heartland Value Fund
$6.8M position · as of 2026-06-30
0.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Executive pay vs shareholder return · Ms. Lachance
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$2.9M
$4.5M
$1.3M
+3%
n/a
2024
$2.5M
$1.8M
$1.3M
-50%
n/a
2023
$2.3M
$2.4M
$1.2M
-38%
n/a
2022
$1.5M
$109.1K
$821.2K
-49%
n/a
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
3 insiders reported buying shares.
The record shows a net $131.5K bought by insiders over 180 days, 56 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
PENBLFSMTDSIBNWRBYISRGTXGDXCMEWTMDXOMIRMD

INFU financials

Revenue growth
+6.4%
XBRL, annual
Net margin
4.6%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$143.3M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
+6.0%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$22.9M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.35x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Cash flow to debt
1.14x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Return on equity
+15.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+8.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
+12.1%
operating income after a 30.0% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on capital employed
+15.9%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
34.85x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
$297.1M
market value at close 2026-10-23 on 2026-07-31 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
FCF yield
+8.3%
TTM free cash flow over market value at close 2026-10-23
PEG, trailing
0.47x
P/E over trailing EPS growth of 74%: four quarters to 2026-06-30 against the four to 2025-06-30
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$143.4M$134.9M$125.8M$109.9M
Gross profit$80.3M$70.4M$63.1M$60.6M
Operating income$11.9M$6.9M$4.1M$1.7M
Net income$6.6M$2.3M$872.0K$18.0K
EPS (diluted)0.310.110.040.00
Operating cash flow$24.4M$20.5M$11.2M$17.5M
Cash$3.2M$527.0K$231.0K$165.0K
Long-term debt$19.6M$23.9M$29.1M$33.2M
Buybacks$9.9M$1.2M$153.0K$5.5M
SEC XBRL, fiscal years, as known on 2026-10-27

INFU Stock Sonar score 6/7 axes

Find similar shapesCompare

INFU ranks highest on profitability (79th percentile) and insider conviction (79th), and lowest on growth (39th), among Medical Devices peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
79
Inputs
  • Return on equity+15.0% · 83 pct, sector of 183
  • Return on assets+8.6% · 85 pct, sector of 214
  • Return on invested capital+12.1% · 57 pct, sector of 36
  • Return on capital employed+15.9% · 91 pct, sector of 188
Financial health
69
Inputs
  • Debt to equity0.35x · 46 pct, sector of 159
  • Cash flow to debt1.14x · 91 pct, sector of 150
Growth
39
Inputs
  • Revenue growth, YoY+6.4% · 39 pct, sector of 219
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
79
Inputs
  • Net Form 4 buying (codes P and S), 180d$131K · 73 pct, sector of 140
  • Insider buyers, 180d3 · 84 pct, sector of 142
Institutional and government
46
Inputs
  • Funds adding, latest quarter56 · 46 pct, sector of 191
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
69
Inputs
  • Short interest, % of float+4.6% · 51 pct, sector of 240
  • Recalls per $1B revenue, 3y0.00 per $1B · 100 pct, sector of 116
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+9.5% · 56 pct, sector of 198
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

INFU filings, in plain words

Are InfuSystem insiders buying or selling INFU?

In the 180 days to 2026-10-27, InfuSystem insiders were net buyers, a net $131.5K across purchases and sales reported on Form 4, by 3 buyers.

Read the full summary

In the 180 days to 2026-10-27, InfuSystem insiders were net buyers of INFU, a net $131.5K across purchases and sales reported on Form 4 by 3 buyers. 3 insiders reported purchases in that window. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies